Retinal Disorders Therapy Market

Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.

Retinal Disorders Therapy Market contains market size and forecasts of Retinal Disorders Therapy in Global, including the following market information:

• Global Retinal Disorders Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Retinal Disorders Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Age Related Macular Degeneration Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Retinal Disorders Therapy include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Retinal Disorders Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Retinal Disorders Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disorders Therapy Market Segment Percentages, by Type, 2021 (%)

• Age Related Macular Degeneration
• Diabetic Retinopathy
• Ocular Inflammatory Disease (Uveitis)
• Macular Hole

Global Retinal Disorders Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disorders Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Retinal Disorders Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Retinal Disorders Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Retinal Disorders Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Retinal Disorders Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ALLERGAN
• AbbVie
• Alimera Sciences
• Janssen Biotech
• Swedish Orphan Biovitrum
• Roche
• Bristol-Myers Squibb
• Genzyme
• Genentech
• OCULAR THERAPEUTIX
• Bausch & Lomb
• UCBCares
• Aier Eye Hospital
• Alcon Holdings, Inc.
• Eyebright Medical
• Kanghong Pharmaceutical
• Huaxia Eye Hospital
• Xingqi Pharmaceutical